|CD39/adenosine pathway is involved in AIDS progression|
M Nikolova, M Carriere, MA Jenabian, S Limou, M Younas, A K÷k, S HuŰ, ...
PLoS pathogens 7 (7), e1002110, 2011
|Antigen-specific CD4-and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection|
M Nikolova, R Markova, R Drenska, M Muhtarova, Y Todorova, V Dimitrov, ...
Diagnostic microbiology and infectious disease 75 (3), 277-281, 2013
|BY55/CD160 acts as a co‐receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression|
M Nikolova, A Marie‐Cardine, L Boumsell, A Bensussan
International immunology 14 (5), 445-451, 2002
|Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets|
M Nikolova, JD Lelievre, M Carriere, A Bensussan, Y LÚvy
Blood, The Journal of the American Society of Hematology 113 (19), 4556-4565, 2009
|Killer cell immunoglobulin‐like receptor expression delineates in situ SÚzary syndrome lymphocytes|
J Wechsler, M Bagot, M Nikolova, S Parolini, N Martin‐Garcia, L Boumsell, ...
The Journal of Pathology: A Journal of the Pathological Society of Greatá…, 2003
|Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas|
M Bagot, M Nikolova, F Schirm‐Chabanette, J Wechsler, L Boumsell, ...
Annals of the New York Academy of Sciences 941 (1), 31-38, 2001
|Intravenous immunoglobulin up‐regulates the expression of the inhibitory FcγIIB receptor on B cells|
KA Nikolova, AI Tchorbanov, IK Djoumerska‐Alexieva, M Nikolova, ...
Immunology and cell biology 87 (7), 529-533, 2009
|HIV care in Central and Eastern Europe: How close are we to the target?|
D Gokengin, C Oprea, J Begovac, A Horban, AN Zeka, D Sedlacek, ...
International Journal of Infectious Diseases 70, 121-130, 2018
|Engagement of ILT2/CD85j in Sezary syndrome cells inhibits their CD3/TCR signaling|
M Nikolova, P Musette, M Bagot, L Boumsell, A Bensussan
Blood, The Journal of the American Society of Hematology 100 (3), 1019-1025, 2002
|Selective silencing of DNA‐specific B lymphocytes delays lupus activity in MRL/lpr mice|
AI Tchorbanov, EN Voynova, NM Mihaylova, TA Todorov, M Nikolova, ...
European journal of immunology 37 (12), 3587-3596, 2007
|Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells|
M Nikolova, A Tawab, A Marie-Cardine, M Bagot, L Boumsell, ...
Journal of investigative dermatology 116 (5), 731-738, 2001
|The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients|
MH Nikolova, MN Muhtarova, HB Taskov, K Kostov, L Vezenkov, ...
Cellular immunology 237 (2), 96-105, 2005
|Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients|
M Petrova, M Muhtarova, M Nikolova, S Magaev, H Taskov, D Nikolovska, ...
World Journal of Gastroenterology: WJG 12 (35), 5711, 2006
|IgM‐enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu‐SCID mice|
T Vassilev, N Mihaylova, E Voynova, M Nikolova, M Kazatchkine, S Kaveri
Clinical & Experimental Immunology 145 (1), 108-115, 2006
|Functional characterization of neurotensin receptors in human cutaneous T cell lymphoma malignant lymphocytes|
M Ramez, M Bagot, M Nikolova, L Boumsell, A Bensussan, N Vita, ...
Journal of investigative dermatology 117 (3), 687-693, 2001
|Cellular and humoral systemic and mucosal immune responses stimulated in volunteers by an oral polybacterial immunomodulator “Dentavax”|
B Petrunov, S Marinova, R Markova, P Nenkov, S Nikolaeva, M Nikolova, ...
International immunopharmacology 6 (7), 1181-1193, 2006
|Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas|
M Nikolova, M Bagot, L Boumsell, A Bensussan
Leukemia & lymphoma 43 (4), 741-746, 2002
|Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their FcγIIb receptor|
N Mihaylova, E Voynova, A Tchorbanov, M Nikolova, A Michova, ...
International immunology 20 (2), 165-175, 2008
|Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity|
I Alexiev, A Shankar, AMJ Wensing, D Beshkov, I Elenkov, M Stoycheva, ...
Journal of Antimicrobial Chemotherapy 70 (6), 1874-1880, 2015
|High rate of hepatitis B and C coinfections among people living with HIV-1 in Bulgaria: 2010–2014|
I Alexiev, M Alexandrova, E Golkocheva-Markova, P Teoharov, ...
AIDS research and human retroviruses 33 (3), 228-229, 2017